Gilles Salles, MD, PhD

Professor in Hematology Department, Chair of the Lymphoma Study Association (the LYSA), Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre Bénite, France

Professor Gilles Salles, a French university professor and hospital doctor (PU-PH), is Head of the Haematology Department of the Lyon Sud University Hospital Complex and teacher at the Claude Bernard University of Lyon. He conducts a research team since 1996, named nowadays “Clinical and Experimental Models of Lymphomagenesis”at the Cancer Research Center of Lyon (UMR INSERM/CNRS/CLB/UCB 1052/5286) that examines several aspects of lymphoma biology (T- and B-cell models, signalization, genomics biology of splenic marginal zone, prognostic factors in lymphoma). After obtaining a DEA degree in Differentiation, Genetics and Immunology from the Claude Bernard University of Lyon in 1986, Gilles Salles continued his university studies by graduating as a Doctor of Medicine in 1989, obtaining an Advanced Specialised Studies Degree in (DESC) in Cancerology in 1992, and writing an immunology thesis on the signals that regulate the formation of B lymphocytes in 1994. During this period, he was a researcher at the Dana Farber Cancer Institute of the Harvard Medical School of Boston in the United States. From 1996 to 2007, Gilles Salles chaired the Scientific Committee of the Adult Lymphoma Study Group (GELA) and his now the chair of the LYSA (the Lymphoma Study Association), a leading cooperative group in Europe. He is also a member of several international societies, including the American Society of Hematology. 

For more than 20 years, Professor Salles has been especially interested in the clinical and biological study of malignant lymphoma – major focuses of his work include the description and validation of prognostic factors as well as clinical trials in indolent lymphomas. Professor Gilles Salles is the author of more than 300 publications.